ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,748,379 | +11.0% | 2,723,011 | +14.4% | 5.08% | -23.5% |
| Q2 2023 | $8,782,200 | -7.6% | 2,380,000 | -17.1% | 6.65% | +26.1% |
| Q1 2023 | $9,499,700 | -14.7% | 2,870,000 | 0.0% | 5.27% | -6.8% |
| Q4 2022 | $11,135,600 | +58.9% | 2,870,000 | -0.5% | 5.66% | +120.3% |
| Q3 2022 | $7,007,000 | -11.5% | 2,883,710 | -27.9% | 2.57% | -18.9% |
| Q2 2022 | $7,920,000 | +31.1% | 4,000,000 | +21.2% | 3.17% | +56.8% |
| Q1 2022 | $6,039,000 | +29.8% | 3,300,000 | 0.0% | 2.02% | +57.5% |
| Q4 2021 | $4,653,000 | – | 3,300,000 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $4,415,000 | 5.01% |
| Aisling Capital LLC | 3,608,171 | $11,113,000 | 1.83% |
| Iguana Healthcare Management, LLC | 1,130,000 | $3,480,000 | 0.96% |
| Consonance Capital Management LP | 1,273,933 | $3,924,000 | 0.43% |
| Perceptive Advisors | 1,442,204 | $4,442,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,000 | $120,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 11,673 | $36,000 | 0.00% |
| Renaissance Technologies | 20,300 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 2 | $0 | 0.00% |
| VANGUARD GROUP INC | 311,514 | $960,000 | 0.00% |